Listed

Aurinia Pharmaceuticals Inc.

AUPHNasdaqCIK 1600620HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$83.2m, Q2 FY2026
Operating income$46.3m, Q2 FY2026
Net income$37.4m, Q2 FY2026
Aurinia Pharmaceuticals Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m54.5Revenue, Q3 FY2023, three months to 2023-09-30$54.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure45.1Revenue, Q4 FY2023, three months to 2023-12-31$45.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure50.3Revenue, Q1 FY2024, three months to 2024-03-31$50.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure57.2Revenue, Q2 FY2024, three months to 2024-06-30$57.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure67.8Revenue, Q3 FY2024, three months to 2024-09-30$67.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure59.9Revenue, Q4 FY2024, three months to 2024-12-31$59.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure62.5Revenue, Q1 FY2025, three months to 2025-03-31$62.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure70.0Revenue, Q2 FY2025, three months to 2025-06-30$70.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure73.5Revenue, Q3 FY2025, three months to 2025-09-30$73.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure77.1Revenue, Q4 FY2025, three months to 2025-12-31$77.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure77.7Revenue, Q1 FY2026, three months to 2026-03-31$77.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure83.2Revenue, Q2 FY2026, three months to 2026-06-30$83.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure
Cost of revenue$m6.8Cost of revenue, Q3 FY2023, three months to 2023-09-30$6.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-07, accession 0001600620-24-000108.Report this figure5.4Cost of revenue, Q4 FY2023, three months to 2023-12-31$5.4m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure7.8Cost of revenue, Q1 FY2024, three months to 2024-03-31$7.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-12, accession 0001600620-25-000049.Report this figure8.9Cost of revenue, Q2 FY2024, three months to 2024-06-30$8.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-07-31, accession 0001600620-25-000092.Report this figure6.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$6.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure5.6Cost of revenue, Q4 FY2024, three months to 2024-12-31$5.6m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure8.6Cost of revenue, Q1 FY2025, three months to 2025-03-31$8.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure7.1Cost of revenue, Q2 FY2025, three months to 2025-06-30$7.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure8.2Cost of revenue, Q3 FY2025, three months to 2025-09-30$8.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure8.8Cost of revenue, Q4 FY2025, three months to 2025-12-31$8.8m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure6.5Cost of revenue, Q1 FY2026, three months to 2026-03-31$6.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure6.6Cost of revenue, Q2 FY2026, three months to 2026-06-30$6.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure
Research and development$m13.6Research and development, Q3 FY2023, three months to 2023-09-30$13.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001600620-24-000108.Report this figure10.2Research and development, Q4 FY2023, three months to 2023-12-31$10.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure5.6Research and development, Q1 FY2024, three months to 2024-03-31$5.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001600620-25-000049.Report this figure4.1Research and development, Q2 FY2024, three months to 2024-06-30$4.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-31, accession 0001600620-25-000092.Report this figure3.0Research and development, Q3 FY2024, three months to 2024-09-30$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure8.1Research and development, Q4 FY2024, three months to 2024-12-31$8.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure5.7Research and development, Q1 FY2025, three months to 2025-03-31$5.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure7.4Research and development, Q2 FY2025, three months to 2025-06-30$7.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure8.4Research and development, Q3 FY2025, three months to 2025-09-30$8.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure10.9Research and development, Q4 FY2025, three months to 2025-12-31$10.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure7.5Research and development, Q1 FY2026, three months to 2026-03-31$7.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure13.1Research and development, Q2 FY2026, three months to 2026-06-30$13.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure
Operating income$m(16.3)Operating income, Q3 FY2023, three months to 2023-09-30−$16.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure(29.7)Operating income, Q4 FY2023, three months to 2023-12-31−$29.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure(13.3)Operating income, Q1 FY2024, three months to 2024-03-31−$13.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure(1.5)Operating income, Q2 FY2024, three months to 2024-06-30−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure11.7Operating income, Q3 FY2024, three months to 2024-09-30$11.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure(1.7)Operating income, Q4 FY2024, three months to 2024-12-31−$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure21.8Operating income, Q1 FY2025, three months to 2025-03-31$21.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure20.1Operating income, Q2 FY2025, three months to 2025-06-30$20.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure29.7Operating income, Q3 FY2025, three months to 2025-09-30$29.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure33.2Operating income, Q4 FY2025, three months to 2025-12-31$33.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure41.4Operating income, Q1 FY2026, three months to 2026-03-31$41.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure46.3Operating income, Q2 FY2026, three months to 2026-06-30$46.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure
Interest expense$m1.4Interest expense, Q3 FY2023, three months to 2023-09-30$1.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-02, accession 0001600620-23-000044.Report this figure1.3Interest expense, Q4 FY2023, three months to 2023-12-31$1.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-15, accession 0001600620-24-000012. Derived: 12-month figure less the 9-month figure.Report this figure1.3Interest expense, Q1 FY2024, three months to 2024-03-31$1.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-02, accession 0001600620-24-000051.Report this figure1.2Interest expense, Q2 FY2024, three months to 2024-06-30$1.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-01, accession 0001600620-24-000091.Report this figure1.2Interest expense, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure1.1Interest expense, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure1.1Interest expense, Q1 FY2025, three months to 2025-03-31$1.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure1.1Interest expense, Q2 FY2025, three months to 2025-06-30$1.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure1.1Interest expense, Q3 FY2025, three months to 2025-09-30$1.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure1.0Interest expense, Q4 FY2025, three months to 2025-12-31$1.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure1.0Interest expense, Q1 FY2026, three months to 2026-03-31$1.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure0.9Interest expense, Q2 FY2026, three months to 2026-06-30$948.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure
Income tax$m0.3Income tax, Q3 FY2023, three months to 2023-09-30$298.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001600620-24-000108.Report this figure0.5Income tax, Q4 FY2023, three months to 2023-12-31$459.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure0.7Income tax, Q1 FY2024, three months to 2024-03-31$739.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0001600620-25-000049.Report this figure0.8Income tax, Q2 FY2024, three months to 2024-06-30$756.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-31, accession 0001600620-25-000092.Report this figure0.5Income tax, Q3 FY2024, three months to 2024-09-30$457.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure(0.3)Income tax, Q4 FY2024, three months to 2024-12-31−$256.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure1.0Income tax, Q1 FY2025, three months to 2025-03-31$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure0.6Income tax, Q2 FY2025, three months to 2025-06-30$643.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure0.4Income tax, Q3 FY2025, three months to 2025-09-30$411.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure(175)Income tax, Q4 FY2025, three months to 2025-12-31−$175.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure9.6Income tax, Q1 FY2026, three months to 2026-03-31$9.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure11.4Income tax, Q2 FY2026, three months to 2026-06-30$11.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure
Net income$m(13.4)Net income, Q3 FY2023, three months to 2023-09-30−$13.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure(26.9)Net income, Q4 FY2023, three months to 2023-12-31−$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure(10.7)Net income, Q1 FY2024, three months to 2024-03-31−$10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure0.7Net income, Q2 FY2024, three months to 2024-06-30$722.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure14.4Net income, Q3 FY2024, three months to 2024-09-30$14.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure1.4Net income, Q4 FY2024, three months to 2024-12-31$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure23.3Net income, Q1 FY2025, three months to 2025-03-31$23.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure21.5Net income, Q2 FY2025, three months to 2025-06-30$21.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure31.6Net income, Q3 FY2025, three months to 2025-09-30$31.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure211Net income, Q4 FY2025, three months to 2025-12-31$210.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure34.4Net income, Q1 FY2026, three months to 2026-03-31$34.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure37.4Net income, Q2 FY2026, three months to 2026-06-30$37.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure
Diluted EPS$ per share(0.09)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure(0.19)Diluted EPS, Q4 FY2023, three months to 2023-12-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure(0.07)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure0.01Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure0.10Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure0.01Diluted EPS, Q4 FY2024, three months to 2024-12-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure0.16Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure0.16Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure0.23Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure1.53Diluted EPS, Q4 FY2025, three months to 2025-12-31$1.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure0.25Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure0.28Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure
Basic EPS$ per share(0.09)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure(0.19)Basic EPS, Q4 FY2023, three months to 2023-12-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure(0.07)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure0.01Basic EPS, Q2 FY2024, three months to 2024-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure0.10Basic EPS, Q3 FY2024, three months to 2024-09-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure0.01Basic EPS, Q4 FY2024, three months to 2024-12-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure0.17Basic EPS, Q1 FY2025, three months to 2025-03-31$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure0.16Basic EPS, Q2 FY2025, three months to 2025-06-30$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure0.24Basic EPS, Q3 FY2025, three months to 2025-09-30$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure1.60Basic EPS, Q4 FY2025, three months to 2025-12-31$1.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure0.26Basic EPS, Q1 FY2026, three months to 2026-03-31$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure0.29Basic EPS, Q2 FY2026, three months to 2026-06-30$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure

Balance sheet

Cash and equivalents$179.7m, Q2 FY2026
Shareholders' equity$614.9m, Q2 FY2026
Aurinia Pharmaceuticals Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m45.6Cash and equivalents, Q3 FY2023, at 2023-09-30$45.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001600620-24-000108.Report this figure48.8Cash and equivalents, FY2023, at 2023-12-31$48.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure63.9Cash and equivalents, Q1 FY2024, at 2024-03-31$63.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001600620-25-000049.Report this figure33.3Cash and equivalents, Q2 FY2024, at 2024-06-30$33.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-31, accession 0001600620-25-000092.Report this figure36.6Cash and equivalents, Q3 FY2024, at 2024-09-30$36.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure83.4Cash and equivalents, FY2024, at 2024-12-31$83.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure66.1Cash and equivalents, Q1 FY2025, at 2025-03-31$66.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure52.9Cash and equivalents, Q2 FY2025, at 2025-06-30$52.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure72.9Cash and equivalents, Q3 FY2025, at 2025-09-30$72.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure80.2Cash and equivalents, FY2025, at 2025-12-31$80.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure40.7Cash and equivalents, Q1 FY2026, at 2026-03-31$40.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure180Cash and equivalents, Q2 FY2026, at 2026-06-30$179.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure
Current assets$m426Current assets, Q3 FY2023, at 2023-09-30$426.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0001600620-23-000044.Report this figure425Current assets, FY2023, at 2023-12-31$424.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure398Current assets, Q1 FY2024, at 2024-03-31$398.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0001600620-24-000051.Report this figure410Current assets, Q2 FY2024, at 2024-06-30$409.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-01, accession 0001600620-24-000091.Report this figure440Current assets, Q3 FY2024, at 2024-09-30$440.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001600620-24-000108.Report this figure447Current assets, FY2024, at 2024-12-31$446.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure406Current assets, Q1 FY2025, at 2025-03-31$405.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001600620-25-000049.Report this figure409Current assets, Q2 FY2025, at 2025-06-30$409.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-31, accession 0001600620-25-000092.Report this figure439Current assets, Q3 FY2025, at 2025-09-30$438.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure492Current assets, FY2025, at 2025-12-31$492.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure480Current assets, Q1 FY2026, at 2026-03-31$480.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure541Current assets, Q2 FY2026, at 2026-06-30$541.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure
Total assets$m555Total assets, Q3 FY2023, at 2023-09-30$555.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0001600620-23-000044.Report this figure548Total assets, FY2023, at 2023-12-31$548.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure517Total assets, Q1 FY2024, at 2024-03-31$516.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0001600620-24-000051.Report this figure524Total assets, Q2 FY2024, at 2024-06-30$523.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0001600620-24-000091.Report this figure549Total assets, Q3 FY2024, at 2024-09-30$549.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001600620-24-000108.Report this figure551Total assets, FY2024, at 2024-12-31$550.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure505Total assets, Q1 FY2025, at 2025-03-31$504.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001600620-25-000049.Report this figure503Total assets, Q2 FY2025, at 2025-06-30$502.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-31, accession 0001600620-25-000092.Report this figure528Total assets, Q3 FY2025, at 2025-09-30$527.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure752Total assets, FY2025, at 2025-12-31$751.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure724Total assets, Q1 FY2026, at 2026-03-31$724.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure792Total assets, Q2 FY2026, at 2026-06-30$792.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure
Current liabilities$m73.9Current liabilities, Q3 FY2023, at 2023-09-30$73.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0001600620-23-000044.Report this figure77.2Current liabilities, FY2023, at 2023-12-31$77.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure71.1Current liabilities, Q1 FY2024, at 2024-03-31$71.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0001600620-24-000051.Report this figure76.9Current liabilities, Q2 FY2024, at 2024-06-30$76.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-01, accession 0001600620-24-000091.Report this figure78.6Current liabilities, Q3 FY2024, at 2024-09-30$78.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001600620-24-000108.Report this figure97.8Current liabilities, FY2024, at 2024-12-31$97.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure68.4Current liabilities, Q1 FY2025, at 2025-03-31$68.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001600620-25-000049.Report this figure78.3Current liabilities, Q2 FY2025, at 2025-06-30$78.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-31, accession 0001600620-25-000092.Report this figure76.2Current liabilities, Q3 FY2025, at 2025-09-30$76.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure93.7Current liabilities, FY2025, at 2025-12-31$93.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure86.6Current liabilities, Q1 FY2026, at 2026-03-31$86.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure99.9Current liabilities, Q2 FY2026, at 2026-06-30$99.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure
Total liabilities$m163Total liabilities, Q3 FY2023, at 2023-09-30$163.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-02, accession 0001600620-23-000044.Report this figure170Total liabilities, FY2023, at 2023-12-31$170.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0001600620-25-000011.Report this figure157Total liabilities, Q1 FY2024, at 2024-03-31$157.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-02, accession 0001600620-24-000051.Report this figure159Total liabilities, Q2 FY2024, at 2024-06-30$158.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-01, accession 0001600620-24-000091.Report this figure161Total liabilities, Q3 FY2024, at 2024-09-30$161.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001600620-24-000108.Report this figure173Total liabilities, FY2024, at 2024-12-31$173.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure155Total liabilities, Q1 FY2025, at 2025-03-31$154.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001600620-25-000049.Report this figure167Total liabilities, Q2 FY2025, at 2025-06-30$167.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-31, accession 0001600620-25-000092.Report this figure162Total liabilities, Q3 FY2025, at 2025-09-30$161.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure170Total liabilities, FY2025, at 2025-12-31$170.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure156Total liabilities, Q1 FY2026, at 2026-03-31$156.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure177Total liabilities, Q2 FY2026, at 2026-06-30$177.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure
Shareholders' equity$m392Shareholders' equity, Q3 FY2023, at 2023-09-30$391.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001600620-24-000108.Report this figure378Shareholders' equity, FY2023, at 2023-12-31$378.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001600620-26-000017.Report this figure359Shareholders' equity, Q1 FY2024, at 2024-03-31$359.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure365Shareholders' equity, Q2 FY2024, at 2024-06-30$364.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure388Shareholders' equity, Q3 FY2024, at 2024-09-30$388.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure377Shareholders' equity, FY2024, at 2024-12-31$377.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure350Shareholders' equity, Q1 FY2025, at 2025-03-31$350.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure335Shareholders' equity, Q2 FY2025, at 2025-06-30$335.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure366Shareholders' equity, Q3 FY2025, at 2025-09-30$365.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure581Shareholders' equity, FY2025, at 2025-12-31$581.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure568Shareholders' equity, Q1 FY2026, at 2026-03-31$567.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure615Shareholders' equity, Q2 FY2026, at 2026-06-30$614.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure

Cash flow

Operating cash flow$52.6m, Q2 FY2026
Share repurchases$38.7m, Q2 FY2026
Aurinia Pharmaceuticals Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(13.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$13.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001600620-24-000108. Derived: 9-month figure less the 6-month figure.Report this figure14.3Operating cash flow, Q4 FY2023, three months to 2023-12-31$14.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(18.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$18.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001600620-25-000049.Report this figure15.8Operating cash flow, Q2 FY2024, three months to 2024-06-30$15.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-31, accession 0001600620-25-000092. Derived: 6-month figure less the 3-month figure.Report this figure17.0Operating cash flow, Q3 FY2024, three months to 2024-09-30$17.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001600620-25-000106. Derived: 9-month figure less the 6-month figure.Report this figure30.1Operating cash flow, Q4 FY2024, three months to 2024-12-31$30.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure1.3Operating cash flow, Q1 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure44.2Operating cash flow, Q2 FY2025, three months to 2025-06-30$44.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001600620-26-000062. Derived: 6-month figure less the 3-month figure.Report this figure44.4Operating cash flow, Q3 FY2025, three months to 2025-09-30$44.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001600620-25-000106. Derived: 9-month figure less the 6-month figure.Report this figure45.7Operating cash flow, Q4 FY2025, three months to 2025-12-31$45.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure32.6Operating cash flow, Q1 FY2026, three months to 2026-03-31$32.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure52.6Operating cash flow, Q2 FY2026, three months to 2026-06-30$52.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001600620-26-000062. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-07, accession 0001600620-24-000108. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure12.3Share repurchases, Q1 FY2024, three months to 2024-03-31$12.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-12, accession 0001600620-25-000049.Report this figure6.1Share repurchases, Q2 FY2024, three months to 2024-06-30$6.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-07-31, accession 0001600620-25-000092. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-04, accession 0001600620-25-000106. Derived: 9-month figure less the 6-month figure.Report this figure21.8Share repurchases, Q4 FY2024, three months to 2024-12-31$21.8m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure46.9Share repurchases, Q1 FY2025, three months to 2025-03-31$46.9m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure42.6Share repurchases, Q2 FY2025, three months to 2025-06-30$42.6m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001600620-26-000062. Derived: 6-month figure less the 3-month figure.Report this figure8.7Share repurchases, Q3 FY2025, three months to 2025-09-30$8.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-04, accession 0001600620-25-000106. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001600620-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure36.2Share repurchases, Q1 FY2026, three months to 2026-03-31$36.2m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure38.7Share repurchases, Q2 FY2026, three months to 2026-06-30$38.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001600620-26-000062. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)133.53m, Q2 FY2026
Aurinia Pharmaceuticals Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares142Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30141,856,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0001600620-23-000044.Report this figure143Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31142,641,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-02, accession 0001600620-24-000051.Report this figure143Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30142,777,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0001600620-24-000091.Report this figure143Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30142,847,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001600620-24-000108.Report this figure144Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31144,013,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001600620-25-000049.Report this figure144Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30144,110,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-31, accession 0001600620-25-000092.Report this figure146Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30145,651,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure143Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31143,199,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure138Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30137,526,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure136Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30136,008,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001600620-25-000106.Report this figure138Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31137,639,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001600620-26-000049.Report this figure134Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30133,530,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure

Shares outstanding: 133.05mShares outstanding, period not labelled, at 2026-08-05133,051,168 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001600620-26-000062.Report this figure at Aug 5, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.